Bartłomiej Kacprzak and Natalia Siuba-Jarosz*

Orto Med Sport, Lodz, Poland

*Corresponding Author: Natalia Siuba-Jarosz, Orto Med Sport, Lodz, Poland.

Received: February 04, 2022; Published: March 08, 2022

Abstract

The medial collateral ligament (MCL) is the most common knee ligament to be injured during knee trauma. In this paper, we present the conservative treatment of 5 elite football players who sustained MCL injury between May 2020 and October 2021. To help to fasten the injured ligament to grow biological treatment using Orthokine was administered.

Patients underwent supervised rehabilitation from the first day after diagnosis, with the according protocol. After 2-3 weeks, MRI was performed. MRI for all patients showed gradual resolution of ligament oedema, ligament remodeling and reabsorption of the fluid

All of the football players in this cohort returned to play within a relatively short period, which suggests that the rehabilitation regimen was good and in helped to RTP faster than what previous studies have reported after isolated MCL injuries. The results may suggest that use of an autologous interleukin-1 receptor antagonist can be a factor that can shorten RTP time.

Keywords: Football; Medial Collateral Ligament

References

1. Vosoughi F, Rezaei Dogahe R, Nuri A, Ayati Firoozabadi M, Mortazavi J. Medial Collateral Ligament Injury of the Knee: A Review on Current Concept and Management. Arch Bone Jt Surg. 2021;9(3):255-262. doi:10.22038/abjs.2021.48458.2401
2. Memarzadeh A, Melton JTK. Medial collateral ligament of the knee: anatomy, management and surgical techniques for reconstruction. Orthop Trauma. 2019;33(2):91-99. doi:10.1016/j.mporth.2019.01.004
3. Warme WJ, Feagin JA, King P, Lambert KL, Cunningham RR. Ski injury statistics, 1982 to 1993, Jackson Hole Ski Resort. Am J Sports Med. 1995;23(5):597-600. doi:10.1177/036354659502300514
4. Reider B, Sathy MR, Talkington J, Blyznak N, Kollias S. Treatment of isolated medial collateral ligament injuries in athletes with early functional rehabilitation. A five-year follow-up study. Am J Sports Med. 1994;22(4):470-477. doi:10.1177/036354659402200406
5. Phisitkul P, James SL, Wolf BR, Amendola A. MCL Injuries of the Knee: Current Concepts Review. Iowa Orthop J. 2006;26:77-90.
6. Lind M, Jakobsen BW, Lund B, Hansen MS, Abdallah O, Christiansen SE. Anatomical Reconstruction of the Medial Collateral Ligament and Posteromedial Corner of the Knee in Patients With Chronic Medial Collateral Ligament Instability. Am J Sports Med. 2009;37(6):1116-1122. doi:10.1177/0363546509332498
7. Kacprzak B, Siuba N, Synder MA, Synde M. The Jumper’s Knee - a New Look at Non-surgical Treatment. Pilot Study. Ortop Traumatol Rehabil. 2020;22(5):347-359. doi:10.5604/01.3001.0014.4225
8. DeHaven KE, Cosgarea AJ, Sebastianelli WJ. Arthrofibrosis of the knee following ligament surgery. Instr Course Lect. 2003;52:369-381.
9. Lundblad M, Hägglund M, Thomeé C, et al. Medial collateral ligament injuries of the knee in male professional football players: a prospective three-season study of 130 cases from the UEFA Elite Club Injury Study. Knee Surg Sports Traumatol Arthrosc Off J ESSKA. 2019;27(11):3692-3698. doi:10.1007/s00167-019-05491-6
10. Varelas AN, Erickson BJ, Cvetanovich GL, Bach BR. Medial Collateral Ligament Reconstruction in Patients With Medial Knee Instability: A Systematic Review. Orthop J Sports Med. 2017;5(5):2325967117703920. doi:10.1177/2325967117703920
11. Jacobson KE, Chi FS. Evaluation and treatment of medial collateral ligament and medial-sided injuries of the knee. Sports Med Arthrosc Rev. 2006;14(2):58-66. doi:10.1097/01.jsa.0000212305.47323.58

Citation

Citation: Bartłomiej Kacprzak and Natalia Siuba-Jarosz. “Could Use of Autologous Interleukin-1 Receptor Antagonist Fasten the Return to Sport Time after Sustained Medial Collateral Ligament Injury? Case Series Report".Acta Scientific Orthopaedics 5.4 (2022): 58-61.

Copyright

Copyright: © 2022 Bartłomiej Kacprzak and Natalia Siuba-Jarosz. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.